Similarly, high PTPRN or SCG5 expression was found to be favorable for PAAD patients; more intense staining was observed in normal pancreatic tissue, suggesting their expression is lowered during tumorigenesis. The gene discussed is SCG5; the disease is pancreatic adenocarcinoma.